(20R)-Ginsenoside Rh1

CAS No. 80952-71-2

(20R)-Ginsenoside Rh1 ( —— )

Catalog No. M19132 CAS No. 80952-71-2

20S, 20R ginsenoside-Rh1 can inhibit the thrombin-induced conversion of fibrinogen to fibrin.

Purity : 98%

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 49 In Stock
10MG 87 In Stock
25MG 157 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    (20R)-Ginsenoside Rh1
  • Note
    Research use only, not for human use.
  • Brief Description
    20S, 20R ginsenoside-Rh1 can inhibit the thrombin-induced conversion of fibrinogen to fibrin.
  • Description
    20S, 20R ginsenoside-Rh1 can inhibit the thrombin-induced conversion of fibrinogen to fibrin.
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    Others-Field
  • Indication
    ——

Chemical Information

  • CAS Number
    80952-71-2
  • Formula Weight
    638.9
  • Molecular Formula
    C36H62O9
  • Purity
    98%
  • Solubility
    ——
  • SMILES
    O1[C@H]([C@@H]([C@H]([C@@H]([C@H]1CO)O)O)O)O[C@@H]1[C@H]2C([C@H](CC[C@@]2([C@@H]2[C@@](C1)([C@@]1(CC[C@@H]([C@H]1[C@@H](C2)O)[C@@](C)(CCC=C(C)C)O)C)C)C)O)(C)C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Yu HS,et al. [Chemical constituents from processed rhizomes of Panax notoginseng]. Zhongguo Zhong Yao Za Zhi. 2013 Nov;38(22):3910-7.
molnova catalog
related products
  • Sulfabenzamide

    Sulfabenzamide is an antibacterial/antimicrobial.

  • N-Boc-4-pentyne-1-am...

    N-Boc-4-pentyne-1-amine is a PROTAC linker, which refers to the alkyl chain composition. N-Boc-4-pentyne-1-amine can be used in the synthesis of the PROTAC MG-277.

  • Terrestrosin D

    Terrestrosin D can induce apoptotic cell death and inhibit angiogenesis in xenograft tumor cells, cell cycle arrest and induction of apoptosis in cancer cells and endothelial cells might be plausible mechanisms of actions for the observed antitumor and antiangiogenic activities of terrestrosin D.